Medicus Pharma Ltd.
MDCX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001997296
No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesMDCXW
13F holders, Q1 2026
Institutional positions in Medicus Pharma Ltd. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q4 2025
- Shares held
- 2.32M
- −1.62M (−41.1%) vs. Q4 2025
- Total value
- $301.6K
- −$5.73M (−95.0%) vs. Q4 2025
- New holders
- 7
- 6 more added
- Sold out
- 7
- 3 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.18M |
| Q1 2026 | 21 | $301.6K |
| Q4 2025 | 21 | $6.03M |
| Q3 2025 | 20 | $4.91M |
| Q2 2025 | 21 | $6.60M |
| Q1 2025 | 7 | $11.4M |
| Q4 2024 | 3 | $3.74M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Medicus Pharma Ltd.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hazlett, Burt & Watson, Inc. | 425 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 75 | $34 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 121 | $56 | 0.00% | +121 | New |
| Jones Financial Companies LLLP | 400 | $180 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,468 | $2.51K | 0.00% | −12,838−70.1% | Reduced |
| Advisor Group Holdings, Inc. | 8,500 | $3.91K | 0.00% | 00.0% | Unchanged |
| Brave Asset Management Inc | 10,000 | $4.56K | 0.00% | −10,000−50.0% | Reduced |
| Smithfield Trust Co | 11,480 | $5.00K | 0.00% | −2,403−17.3% | Reduced |
| StoneX Group Inc. | 15,169 | $6.96K | 0.00% | +15,169 | New |
| Marathon Capital Management | 15,500 | $7.12K | 0.00% | +15,500 | New |
| LPL Financial LLC | 15,612 | $7.17K | 0.00% | +15,612 | New |
| Two Sigma Securities, LLC | 15,617 | $7.17K | 0.00% | +15,617 | New |
| Citadel Advisors LLC | 17,824 | $8.18K | 0.00% | +17,824 | New |
| BlackRock, Inc. | 37,294 | $17.1K | 0.00% | +2,977+8.7% | Added |
| UBS Group AG | 40,441 | $18.6K | 0.00% | +27,210+205.7% | Added |
| Commonwealth Equity Services, LLC | 48,143 | $22.1K | 0.00% | +19,650+69.0% | Added |
| May Hill Capital, LLC | 50,622 | $23.2K | 0.01% | +15,000+42.1% | Added |
| Bryn Mawr Trust Co | 51,244 | $23.5K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 74,045 | $34.0K | 0.00% | +74,045 | New |
| Private Advisor Group, LLC | 240,055 | $110.2K | 0.00% | +64,560+36.8% | Added |
| Interchange Capital Partners, LLC | 1,661,871 | – | – | +75,000+4.7% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,810,960−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −60,337−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −40,162−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −27,529−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −12,319−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| DAGCO, Inc. | 0 | $0 | 0.00% | −349−100.0% | Sold out |